MEDIUM confidence
Researched 2026-08-04 21:01 · profile: startup
Programme Thesis
The USAID Development Innovation Funding program provides grants to support innovative, scalable solutions that address critical development challenges in low- and middle-income countries, with a focus on digital health and other sectors. It exists to catalyze early-stage, high-impact ideas that can improve health outcomes and economic resilience in underserved communities.
Selection Criteria
- Alignment with USAID's mission to promote sustainable development and improve health outcomes in low-income settings.
- Innovation and novelty of the proposed solution.
- Feasibility and technical soundness of the approach.
- Potential for scalability and long-term sustainability.
- Capacity of the applicant team to execute the project.
- Clear, measurable impact on target populations.
- Cost-effectiveness and value for money.
- Alignment with local needs and context (e.g., Nigeria).
Past Winners / Cohort Profiles
Past winners typically include social enterprises, non-profits, and early-stage startups that have developed practical, low-cost digital health tools, mobile health apps, or community-based health delivery models. Examples include SMS-based health information systems, telemedicine platforms, and supply chain management tools for essential medicines. Winners often have strong local partnerships and a clear path to scale.
Ideal Candidate Fingerprint
The ideal applicant is a mission-driven, early-stage venture with a proven prototype that directly addresses a pressing health challenge in a low-income country. They have a strong local presence or partnership, a clear theory of change, and a scalable business model that can operate with minimal external support. The team is technically capable and demonstrates a deep understanding of the local context and user needs.
Recommended Framing
For Eniola Olutogun, the strongest angle is to frame the venture as a digital health innovation that improves prescription drug access in Nigeria, leveraging AI to predict drug resistance and optimize treatment. This directly aligns with USAID's focus on digital health in low-income settings, and the founder's pharmacist background adds credibility. The pitch should emphasize the potential to reduce antimicrobial resistance and improve patient outcomes in resource-limited settings, while highlighting the venture's scalability and local relevance.
Watch Out
The venture is not yet incorporated, which may be a barrier for USAID grants that often require a legal entity. Additionally, the technology is primarily computational and may not have a clear field deployment plan in low-income settings. The broad eligibility and high competition may also disadvantage a pre-seed startup without prior grant experience.